Dynavax Technologies Corporation news

   Watch this stock
Showing stories 1 - 7 of about 7   

Articles published

DVAX 21.74 -0.24 (-1.09%)
price chart
85% Probability Of FDA Approval For Dynavax's Heplisav, Says Cowen's Senior ...
One of them is Dynavax Technologies (NASDAQ:DVAX), a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
Dynavax Shares Poised To Run Higher As Hepsaliv Approaches Important ...
Dynavax Technologies (NASDAQ:DVAX) is a clinical-stage biopharmaceutical company that discovers and develops novel products to prevent and treat infectious and inflammatory diseases.
Lightning Round: Ford, Sirius XM, Intel & More
Intel : I haven't liked what I've heard about the PC market, said Cramer, but I haven't listened to the conference call yet.
6 Stocks Trading Under $5 on Winning Streaks
Dynavax Technologies Corporation (DVAX, Earnings, Analysts, Financials): A clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases.
Small Cap Biotech Stocks With Hepatitis Exposure: ABT, BMY, GSK, GIL, JNJ ...
Dynavax Technologies Corporation (NASDAQ: DVAX). A clinical-stage biopharmaceutical company, Dynavax Technologies Corporation discovers and develops products to prevent and treat infectious and inflammatory diseases. On the Hepatitis front, ...
Risk Vs. Reward Never Gets Old
Everything one needs for a wild ride in a biotech company. The reason I like ... Dynavax Technologies has a number of promising drugs, with HEPLISAVTM being their prize, as it treats Hepatitis B, which afflicts 350 million people worldwide.
Biodefense Industry - Market to Benefit from Federal Funding such as the BIO ...
7.2.1 Biodefense Contracts 31. 7.3 Bavarian Nordic 32. 7.3.1 Biodefense Contracts 32. 7.4 Cleveland BioLabs 33. 7.4.1 Biodefense Contracts 33.